Retatrutide is a novel investigational peptide currently under study as a triple receptor agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously. Preclinical and early clinical research has focused on its potential impact on metabolic regulation, including pathways related to energy balance, insulin sensitivity, and body weight management. Scientific interest continues to grow regarding its comparative activity to other GLP-1–based compounds in research models.

Each vial is supplied as lyophilized powder, third-party tested via LC-MS analysis, and ships with a Certificate of Analysis confirming identity and purity.

Specifications: CAS Number: 2381272-77-9 | Molecular Weight: 4,862.5 Da | Purity: >99% | Form: Lyophilized Powder | Storage: -20°C long-term / 4°C short-term

⚠️ For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes. For use by licensed researchers only in controlled laboratory settings.